【24h】

Position on reproductive donors and smallpox vaccine: a committee opinion

机译:关于生殖供体和天花疫苗的立场:委员会的意见

获取原文
获取原文并翻译 | 示例
           

摘要

Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, the Society for Assisted Reproductive Technology (SART) and the American Society for Reproductive Medicine (ASRM) accordingly recommend that assisted reproductive technology (ART) practitioners consider deferring individuals who are planning on donating gametes for reproductive use (reproductive donors) who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that reproductive donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred. This document replaces the previous document of the same name last published in 2012 (Fertil Steril 2012;98:e1-e2). (C) 2016 by American Society for Reproductive Medicine.
机译:尽管目前尚无确切的证据将牛痘病毒通过生殖细胞传播,但辅助生殖技术学会(SART)和美国生殖医学学会(ASRM)相应地建议,辅助生殖技术(ART)的从业者应考虑推迟计划中的个体关于最近通过与疫苗接受者密切接触而接受天花疫苗或感染有症状痘苗病毒感染的供生殖用配子(生殖供体)的通知(直到疫苗或传染性sc疮自发分离后)。良好的捐助者作法进一步表明,身体状况不佳的生殖捐助者,包括最近因天花疫苗而出现并发症的捐助者,应同样推迟。本文档替代了上一次于2012年发布的同名文档(Fertil Steril 2012; 98:e1-e2)。 (C)2016年,美国生殖医学学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号